Literature DB >> 28776160

[Acute monocular loss of vision : Differential diagnostic considerations apart from the internistic etiological clarification].

A Rickmann1, M A Macek2, P Szurman2, K Boden2.   

Abstract

We report the case of acute painless monocular loss of vision in a 53-year-old man. An interdisciplinary etiological evaluation remained without pathological findings with respect to arterial branch occlusion. A reevaluation of the patient history led to a possible association with the administration of phosphodiesterase type 5 inhibitor (PDE5 inhibitor). A critical review of the literature on PDE5 inhibitor administration with ocular participation was performed.

Entities:  

Keywords:  AION; Branch retinal artery occlusion; PDE 5 inhibitor; Retinal vein occlusion; Sildenafil

Mesh:

Year:  2018        PMID: 28776160     DOI: 10.1007/s00347-017-0555-2

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  18 in total

1.  Branch retinal artery occlusion; another complication of sildenafil.

Authors:  A Tripathi; N P O'Donnell
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

2.  Sildenafil-associated consecutive nonarteritic anterior ischaemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in a haemodialysis patient.

Authors:  S Gedik; G Yilmaz; Y A Akova
Journal:  Eye (Lond)       Date:  2006-05-26       Impact factor: 3.775

3.  Acute angle-closure glaucoma following sildenafil citrate-aided sexual intercourse.

Authors:  Balasubramanian Ramasamy; Fiona Rowe; Harish Nayak; Clive Peckar; Carmel Noonan
Journal:  Acta Ophthalmol Scand       Date:  2007-03

Review 4.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Stepwise decline in visual field after serial sildenafil use.

Authors:  Susan Pepin; Ian Pitha-Rowe
Journal:  J Neuroophthalmol       Date:  2008-03       Impact factor: 3.042

6.  Sildenafil citrate therapy for pulmonary arterial hypertension.

Authors:  Nazzareno Galiè; Hossein A Ghofrani; Adam Torbicki; Robyn J Barst; Lewis J Rubin; David Badesch; Thomas Fleming; Tamiza Parpia; Gary Burgess; Angelo Branzi; Friedrich Grimminger; Marcin Kurzyna; Gérald Simonneau
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

Review 7.  Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature.

Authors:  Faris Azzouni; Khawla Abu samra
Journal:  J Sex Med       Date:  2011-07-19       Impact factor: 3.802

8.  Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat.

Authors:  Ruilan Zhang; Lei Wang; Li Zhang; Jieli Chen; Zhenping Zhu; Zhenggang Zhang; Michael Chopp
Journal:  Circ Res       Date:  2003-02-21       Impact factor: 17.367

9.  Ischemic optic neuropathy in a child.

Authors:  Lalitha Sivaswamy; Gregory P Vanstavern
Journal:  Pediatr Neurol       Date:  2007-11       Impact factor: 3.372

10.  Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension.

Authors:  Lancelot M Pinto; Sunil Morekar; Ashok A Mahashur
Journal:  Indian J Chest Dis Allied Sci       Date:  2009 Oct-Dec
View more
  1 in total

Review 1.  Visual Side Effects Linked to Sildenafil Consumption: An Update.

Authors:  Eva Ausó; Violeta Gómez-Vicente; Gema Esquiva
Journal:  Biomedicines       Date:  2021-03-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.